Pacira Pharma (PCRX) Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Pacira Pharma (PCRX) Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients
PACIRA (NASDAQ: PCRX) Delayed: 23.06 +0.35 (1.54%)
Previous Close $22.71    52 Week High $80.25 
Open $22.90    52 Week Low $30.25 
Day High $23.21    P/E N/A 
Day Low $22.81    EPS $-2.08 
Volume 69,521